[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363972-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363972-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-related-mortality-among-individuals-with-schizophrenia-systematic-review-and-meta-analysis-of-cohort-studies","Cancer-related mortality among individuals with schizophrenia - systematic review and meta-analysis of cohort studies","","Cancer-related mortality among individuals with schizophrenia is assessed through a systematic review and meta-analysis of cohort studies. The study evaluates whether cancer death risk differs from the general population overall, stratified by gender, and by specific cancer sites. Searches cover Scopus, Web of Science, PsycINFO, PubMed, and Embase up to December 2025. Results indicate higher cancer-related death risk in schizophrenia, supporting earlier detection and integrated physical and mental healthcare for this high-risk group.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-related-mortality-among-individuals-with-schizophrenia-systematic-review-and-meta-analysis-of-cohort-studies/363972/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-related-mortality-among-individuals-with-schizophrenia-systematic-review-and-meta-analysis-of-cohort-studies/363972.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of the systematic review and meta-analysis?","Question",{"text":63,"@type":64},"To assess whether cancer-related mortality among individuals with schizophrenia differs from the general population, overall, by gender, and by specific cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies searched and evaluated in the review?",{"text":68,"@type":64},"Records were searched in Scopus, Web of Science, PsycINFO, PubMed, and Embase up to December 2025, screened and extracted independently by multiple reviewers. Quality was assessed using the Newcastle–Ottawa Scale, and analyses were conducted with Stata using heterogeneity tests and exploratory metaregression.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the findings show about cancer-related mortality risk?",{"text":72,"@type":64},"Meta-analysis indicates a 55% higher risk of cancer-related death in individuals with schizophrenia versus the general population, with site-specific increases that vary by cancer type and with differing precision across sites.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363972,1790869807,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| | BJPsych Open (2026)\u003Cbr>12, e206, 1–9 . doi: 10 . 1192/bjo.2026.12068 |\n| --- | --- |\n\n| \u003Cbr>Cancer-related mortality among individuals with schizophrenia: systematic review and meta-analysis of cohort studies\u003Cbr>Seyyed Muhammad Mahdi Mahdavinoor, Aghil Mollaei, Arash Golzar, Saeed Kargar-Soleimanabad, Amir-Hassan Bordbari, Melika Amiri, Mohammad Hosein Rafiee and Leila Seddigh |  |\n| --- | --- |\n| Background\u003Cbr>Individuals with schizophrenia have shown distinct cancer incidence patterns.\u003Cbr>Aims\u003Cbr>We aimed to assess whether their cancer-related mortality differs from the general population overall, by gender and by specific cancer types.\u003Cbr>Method\u003Cbr>We systematically searched Scopus, Web of Science, PsycINFO, PubMed and Embase, up to December 2025 . Each record was independently screened by two reviewers, and data were independently extracted by two investigators. Two authors assessed the quality of the included articles with the Newcastle– Ottawa Scale. Analyses were conducted using Stata version 16; between-study heterogeneity was evaluated with Cochran’s Q-statistic and the I2-statistic, and potential sources of heterogeneity were further examined through exploratory metaregression.\u003Cbr>Results\u003Cbr>Meta-analysis of cohort studies showed that individuals with schizophrenia had a 55% higher risk of cancer-related death than the general population (standardised mortality ratio (SMR) 1.55; 95% CI 1 .16–2.07) . In gender-stratified analyses, SMRs for all | cancers combined were 1.37 (95% CI 1.01–1.87) in men and\u003Cbr>1.43 (95% CI 1 .15–1.79) in women. Site-specific SMRs were\u003Cbr>1.77 (95% CI 1.17–2.68) for breast, 2.40 (95% CI 2.35–2.45) for respiratory, 1.54 (95% CI 1.35–1.76) for gastrointestinal,\u003Cbr>2.32 (95% CI 0.72–7.45) for haematologic, 4.43 (95% CI\u003Cbr>0.71–27.62) for skin and soft tissue, 3.03 (95% CI 1.96–4.69) forurogenital and 1.01 (95% CI: 0.36–2.83) for other cancers, although precision varied considerably across cancer sites.\u003Cbr>Conclusions\u003Cbr>Schizophrenia was associated with substantially elevated cancer-related mortality compared with the general population. These findings underscore the need for earlier cancer detection and guideline-concordant, integrated physical and mental healthcare for this high-risk group.\u003Cbr>Keywords\u003Cbr>Schizophrenia; cancer; mortality; meta-analysis; neoplasms.\u003Cbr>Copyright and usage\u003Cbr>© The Author(s), 2026 . Published by Cambridge University Press on behalf of Royal College of Psychiatrists. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |\n\nSchizophrenia is one of the most severe psychiatric disorders. It is chronic and complex, and occurs across all societies and socioeconomic strata.1,2 The raw estimates of prevalence, incidence and burden of schizophrenia have been increasing since 1990 . From 1990 to 2019, crude prevalence (from 14.2 million to 23.6 million), incidence cases (from 941 000 to 1.3 million), and disabilityadjusted life-years (from 9.1 million to 15.1 million) rose by more than 65, 37 and 65%, respectively.3 Given the large number of people affected by schizophrenia, the difficulties it creates for patients and their families, and the substantial costs it imposes on society, schizophrenia is considered a major public health concern rather than merely a disorder.4–7 Individuals with schizophrenia have a substantially shorter life expectancy than the general population (14.5 years of potential life lost; 95% CI 11.2–17.8) .8 Multiple factors contribute to reduced life expectancy in this population, including unhealthy and sedentary lifestyles,9 delayed diagnosis and discontinuous treatment,10, 11 lower cognitive functioning,12 increased risk of certain cancers,13 diabet","cbCaioUMx9sZXZ57","https://ap.wps.com/l/cbCaioUMx9sZXZ57","pdf",286127,"English","# Background\n# Aims\n# Method\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is the purpose of the systematic review and meta-analysis?\",\"answer\":\"To assess whether cancer-related mortality among individuals with schizophrenia differs from the general population, overall, by gender, and by specific cancer types.\"},{\"question\":\"How were studies searched and evaluated in the review?\",\"answer\":\"Records were searched in Scopus, Web of Science, PsycINFO, PubMed, and Embase up to December 2025, screened and extracted independently by multiple reviewers. Quality was assessed using the Newcastle–Ottawa Scale, and analyses were conducted with Stata using heterogeneity tests and exploratory metaregression.\"},{\"question\":\"What do the findings show about cancer-related mortality risk?\",\"answer\":\"Meta-analysis indicates a 55% higher risk of cancer-related death in individuals with schizophrenia versus the general population, with site-specific increases that vary by cancer type and with differing precision across sites.\"}]","Cancer-related mortality among individuals with schizophrenia - systematic review and meta-analysis of cohort studies | PDF",1790154668,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1ba89fd0b7c606b1b3f9acc4756419a.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebc2f75bdb80f51925d61bfc0040b101.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fc421ed5529dfdd620b1243fd8ef8e7.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce7a353ca7303bf117dc4a7bace4e6bf.webp",980,1385]